Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds

Neurobiology of Aging

Volumn 35, Issue 4, 2014, Pages 899-905

  Loehrer, Elizabeth ^a   Ikram, M Arfan ^a   Akoudad, Saloua ^a   Vrooman, Henri A ^a   van der Lugt, Aad ^a   Niessen, Wiro J ^a,b   Hofman, Albert ^a   Vernooij, Meike W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

APOE; Cerebral microbleeds; Cerebrovascular disease; Epidemiology; Imaging marker; MRI; Population based; Risk factor

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAIN HEMORRHAGE; BRAIN SCINTISCANNING; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBLEED PROXIMITY; NEUROPATHOLOGY; OCCIPITAL LOBE; PRIORITY JOURNAL; SPATIAL DISTRIBUTION; VASCULAR AMYLOIDOSIS;

APOE; CEREBRAL MICROBLEEDS; CEREBROVASCULAR DISEASE; EPIDEMIOLOGY; IMAGING MARKER; MRI; POPULATION-BASED; RISK FACTOR;

AGED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCCIPITAL LOBE; PREVALENCE; RISK FACTORS;

EID: 84891371954     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.09.012     Document Type: Article

References (41)

1. Attems J., Jellinger K., Thal D.R., Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathol. Appl. Neurobiol. 2011, 37:75-93.
2. Auriel E., Greenberg S.M. The pathophysiology and clinical presentation of cerebral amyloid angiopathy. Curr. Atheroscler. Rep. 2012, 14:343-350.
3. Dierksen G.A., Skehan M.E., Khan M.A., Jeng J., Nandigam R.N., Becker J.A., Kumar A., Neal K.L., Betensky R.A., Frosch M.P., Rosand J., Johnson K.A., Viswanathan A., Salat D.H., Greenberg S.M. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann. Neurol. 2010, 68:545-548.
4. Fazekas F., Kleinert R., Roob G., Kleinert G., Kapeller P., Schmidt R., Hartung H.P. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am. J. Neuroradiol. 1999, 20:637-642.
5. Greenberg S.M., Vernooij M.W., Cordonnier C., Viswanathan A., Al-Shahi Salman R., Warach S., Launer L.J., Van Buchem M.A., Breteler M.M., Microbleed Study Group Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009, 8:165-174.
6. Greenberg S.M., Vonsattel J.P., Segal A.Z., Chiu R.I., Clatworthy A.E., Liao A., Hyman B.T., Rebeck G.W. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998, 50:961-965.
7. Grimmer T., Tholen S., Yousefi B.H., Alexopoulos P., Forschler A., Forstl H., Henriksen G., Klunk W.E., Mathis C.A., Perneczky R., Sorg C., Kurz A., Drzezga A. Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease. Biol. Psychiatry 2010, 68:879-884.
8. Gurol M.E., Dierksen G., Betensky R., Gidicsin C., Halpin A., Becker A., Carmasin J., Ayres A., Schwab K., Viswanathan A., Salat D., Rosand J., Johnson K.A., Greenberg S.M. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology 2012, 79:320-326.
9. Hofman A., van Duijn C.M., Franco O.H., Ikram M.A., Janssen H.L., Klaver C.C., Kuipers E.J., Nijsten T.E., Stricker B.H., Tiemeier H., Uitterlinden A.G., Vernooij M.W., Witteman J.C. The Rotterdam Study: 2012 objectives and design update. Eur. J. Epidemiol. 2011, 26:657-686.
10. Ikram M.A., Liu F., Oostra B.A., Hofman A., van Duijn C.M., Breteler M.M. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis. Biol. Psychiatry 2009, 65:995-999.
11. Ikram M.A., van der Lugt A., Niessen W.J., Krestin G.P., Koudstaal P.J., Hofman A., Breteler M.M., Vernooij M.W. The Rotterdam Scan Study: design and update up to 2012. Eur. J. Epidemiol. 2011, 26:811-824.
12. Ikram M.A., Vernooij M.W., Hofman A., Niessen W.J., van der Lugt A., Breteler M.M. Kidney function is related to cerebral small vessel disease. Stroke 2008, 39:55-61.
13. Jeerakathil T., Wolf P.A., Beiser A., Hald J.K., Au R., Kase C.S., Massaro J.M., DeCarli C. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004, 35:1831-1835.
14. Jellinger K.A. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front. Aging Neurosci. 2013, 5:17.
15. Johnson K.A., Gregas M., Becker J.A., Kinnecom C., Salat D.H., Moran E.K., Smith E.E., Rosand J., Rentz D.M., Klunk W.E., Mathis C.A., Price J.C., Dekosky S.T., Fischman A.J., Greenberg S.M. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann. Neurol. 2007, 62:229-234.
16. Klein S., Staring M., Murphy K., Viergever M.A., Pluim J.P. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans. Med. Imaging 2010, 29:196-205.
17. Knudsen K.A., Rosand J., Karluk D., Greenberg S.M. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001, 56:537-539.
18. Lippa C.F., Smith T.W., Saunders A.M., Hulette C., Pulaski-Salo D., Roses A.D. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 1997, 48:515-519.
19. McCarron M.O., Nicoll J.A., Stewart J., Ironside J.W., Mann D.M., Love S., Graham D.I., Dewar D. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J.Neuropathol. Exp. Neurol. 1999, 58:711-718.
20. Mesker D.J., Poels M.M., Ikram M.A., Vernooij M.W., Hofman A., Vrooman H.A., van der Lugt A., Breteler M.M. Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch. Neurol. 2011, 68:656-659.
21. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., Mintun M.A. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann. Neurol. 2010, 67:122-131.
22. Pettersen J.A., Sathiyamoorthy G., Gao F.Q., Szilagyi G., Nadkarni N.K., St George-Hyslop P., Rogaeva E., Black S.E. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch. Neurol. 2008, 65:790-795.
23. Poels M.M., Ikram M.A., van der Lugt A., Hofman A., Krestin G.P., Breteler M.M., Vernooij M.W. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011, 42:656-661.
24. Poels M.M., Vernooij M.W., Ikram M.A., Hofman A., Krestin G.P., van der Lugt A., Breteler M.M. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010, 41(10 suppl):S103-S106.
25. Roob G., Schmidt R., Kapeller P., Lechner A., Hartung H.P., Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999, 52:991-994.
26. Rosand J., Muzikansky A., Kumar A., Wisco J.J., Smith E.E., Betensky R.A., Greenberg S.M. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann. Neurol. 2005, 58:459-462.
27. Rowe C.C., Ellis K.A., Rimajova M., Bourgeat P., Pike K.E., Jones G., Fripp J., Tochon-Danguy H., Morandeau L., O'Keefe G., Price R., Raniga P., Robins P., Acosta O., Lenzo N., Szoeke C., Salvado O., Head R., Martins R., Masters C.L., Ames D., Villemagne V.L. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol. Aging 2010, 31:1275-1283.
28. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A 1993, 90:9649-9653.
29. Schneider J.A., Bennett D.A. Where vascular meets neurodegenerative disease. Stroke 2010, 41(10 suppl):S144-S146.
30. Schrag M., McAuley G., Pomakian J., Jiffry A., Tung S., Mueller C., Vinters H.V., Haacke E.M., Holshouser B., Kido D., Kirsch W.M. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010, 119:291-302.
31. Smith E.E., Nandigam K.R., Chen Y.W., Jeng J., Salat D., Halpin A., Frosch M., Wendell L., Fazen L., Rosand J., Viswanathan A., Greenberg S.M. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke 2010, 41:1933-1938.
32. Sojkova J., Zhou Y., An Y., Kraut M.A., Ferrucci L., Wong D.F., Resnick S.M. Longitudinal patterns of beta-amyloid deposition in nondemented older adults. Arch. Neurol. 2011, 68:644-649.
33. Sveinbjornsdottir S., Sigurdsson S., Aspelund T., Kjartansson O., Eiriksdottir G., Valtysdottir B., Lopez O.L., van Buchem M.A., Jonsson P.V., Gudnason V., Launer L.J. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J.Neurol. Neurosurg. Psychiatry 2008, 79:1002-1006.
34. Thal D.R., Griffin W.S., de Vos R.A., Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol. 2008, 115:599-609.
35. Thal D.R., Grinberg L.T., Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp. Gerontol. 2012, 47:816-824.
36. Tsushima Y., Tanizaki Y., Aoki J., Endo K. MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology 2002, 44:31-36.
37. Vernooij M.W., Ikram M.A., Wielopolski P.A., Krestin G.P., Breteler M.M., van der Lugt A. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology 2008, 248:272-277.
38. Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski P.A., Niessen W.J., Hofman A., Krestin G.P., Breteler M.M. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008, 70:1208-1214.
39. Villain N., Chetelat G., Grassiot B., Bourgeat P., Jones G., Ellis K.A., Ames D., Martins R.N., Eustache F., Salvado O., Masters C.L., Rowe C.C., Villemagne V.L., Group A.R. Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain 2012, 135:2126-2139.
40. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke 1987, 18:311-324.
41. Viswanathan A., Greenberg S.M. Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 2011, 70:871-880.